Literature DB >> 18253108

Why do some biologic agents induce psoriasis or psoriasiform lesions?

Ieda Mm Laurindo1, Morton Scheinberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18253108     DOI： 10.1038/ncprheum0738

Source DB:  PubMed          Journal:  Nat Clin Pract Rheumatol        ISSN： 1745-8382


× No keyword cloud information.
  3 in total

1.  Psoriasis and psoriasiform lesions induced by TNFα antagonists: the experience of a tertiary care hospital from northern Spain.

Authors:  Alejandra López-Robles; Rubén Queiro; Mercedes Alperi; Sara Alonso; José L Riestra; Javier Ballina
Journal:  Rheumatol Int       Date:  2011-12-21       Impact factor: 2.631

2.  Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series.

Authors:  Morton Scheinberg; Regina Adalva de Lucena Couto Océa; Boris Afonso Cruz; Sineida Berbert Ferreira
Journal:  Rheumatol Ther       Date:  2017-07-28

3.  Resistant palmoplantar lesions in patients of psoriasis: evaluation of the causes and comparison of the frequency of delayed-type hypersensitivity in patients without palm and sole lesions.

Authors:  Nawaf Al-Mutairi; Tarek O Abdalla; Tarek M Nour
Journal:  Med Princ Pract       Date:  2014-09-03       Impact factor: 1.927
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.